Premium
Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in Alzheimer's disease patients
Author(s) -
LlorensMartin María
Publication year - 2020
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1002/alz.047288
Subject(s) - neurogenesis , hippocampal formation , dentate gyrus , neuroscience , hippocampus , human brain , disease , memory impairment , population , psychology , medicine , cognition , pathology , environmental health
Background Memory impairment in Alzheimer’s Disease (AD) can be attributed to a significant decline in the functioning of the hippocampal formation, a brain region crucial for learning and memory. Moreover, this structure hosts one of the most unique phenomena of the adult mammalian brain, namely the addition of new neurons throughout lifetime. While synapse loss and consequent death of mature neurons may be responsible for much of the hippocampal malfunctioning in AD, studies in mice suggest that the disease could also target the generation of new neurons – or adult hippocampal neurogenesis (AHN). Nonetheless, direct evidence of AHN in humans has remained elusive. Method We have developed a novel reliable method to study AHN in post‐mortem human brain samples. We revisited the occurrence of continued neurogenesis in the human hippocampus of aged healthy subjects and AD patients, using brain material obtained under tightly controlled conditions and applying state‐of‐the‐art tissue processing methods. Result We observe a dynamic population of immature neurons in the human dentate gyrus at least until the tenth decade of life. Slight variations in histological and tissue processing methodologies have a great impact on the study of AHN in the human DG. AHN is dramatically impaired in AD patients. Conclusion Our data evidence that AHN is a robust phenomenon in the human brain, and points to impaired neurogenesis as a potentially relevant mechanism underlying AD that may be amenable to novel therapeutic strategies.